







One theme that has emerged in the last several years is 
that aging, perhaps better defined as longevity, is a 
complex genetic and cellular process that appears to be 
regulated, at least in part, by a relatively new gene 
family referred to as sirtuins [1,2].  These genes are the 
human and murine homologs of the Saccharomyces 
cerevisiae Sir2 that has been shown to regulate both 
replicative and overall lifespan [3,4].  The sirtuin family 
genes have also been shown to direct longevity in C. 
elegans and D. melanogaster [1,2] suggesting an 
evolutionary conserved need for these proteins in the 
cells in multiple different complex species.  Sirtuins are 
classified as class III histone deacetylases,  which        
are  different  than   traditional   class  I  and  II   histone 
 
 





































deacetylases [5,6]. Unlike conventional HDACs, 
sirtuins have a variety of substrates ranging from 
metabolic enzymes to structural proteins as well as 
histones [7,8]. 
 
The mammalian sirtuin family consists of seven NAD
+-
dependent protein deacetylases[9-11] that share a 
common 275-amino acid catalytic domain and are 
localized to the nucleus (SIRT1, 6, and 7), mitochondria 
(SIRT3, 4, and 5), and cytoplasm (SIRT2), respectively 
[3]. Sirtuins require NAD
+ as a cofactor which 
mechanistically connects their enzymatic activity to the 
metabolism of the cells, and provides link between the 
sirtuin activity and energy and stress responses [12,13].  
Using these findings as a guide, it seems reasonable to 
suggest that sirtuins function as fidelity or watchdog 
Acetylation of MnSOD directs enzymatic activity responding to 
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downstream targets via post-translational modifications 
involving protein acetylation to maintain cellular 
metabolic homeostasis [14].   
 
In this regard, lysine acetylation has recently emerged 
as an important, and perhaps the primary, post-
translational modification employed to regulate 
mitochondrial proteins [14,15].  Several proteomic 
surveys have identified a disproportionately high 
number of acetylated proteins in the mitochondria and 
many of these proteins are associated with energy 
homeostasis [14,16]. Thus, these results suggest that the 
mitochondrial acetylome, which is regulated by both 
acetyl transferases as well as deacetylase such as 
sirtuins, may by the primary means by which the 
mitochondrial regulates energy production and ROS 
levels to match ATP production with intracellular 
energy requirements.  In this regard, three of the seven 
mammalian sirtuins appear to be localized to the 
mitochondria [11], including SIRT3 that is the primary 
mitochondrial deacetylase [17], suggesting a significant 
role for these sirtuins in regulating mitochondrial 
metabolism [12,17].  Thus, we and others hypothesized 
that SIRT3 may act as a maintenance proteins that 
significantly determines the mitochondrial acetylome 
that functions by monitoring critical mitochondrial 
processes such as the regulation of respiration and/or 
metabolite clearance, and initiating a protective and/or 
reparative response.    
 
Based on these results, it seems reasonable to propose 
that acetylation of mitochondrial proteins may play a 
role in maintaining and regulating mitochondrial ROS 
levels as well as function.  Sirt3 is the main 
mitochondrial deacetylase [17], and genetic knockout of 
Sirt3 results in increased ROS, including superoxide 
levels, in vitro and in vivo [12].  Thus, we believe it is a 
logical extension to hypothesize that SIRT3 is a 
regulatory protein, maintaining mitochondrial 
homeostasis via changes in the acetylation of metabolic 
target proteins, including those comprising the 
mitochondrial ROS detoxification system.   
 
We have previously demonstrated that MEFs lacking 
Sirt3 exhibit an immortalization permissive phenotype 
and the knockout mice spontaneously form well 
differentiated, estrogen and progesterone (ER/PR)-
positive mammary tumors [18].  SIRT3 protein levels 
are decreased in human breast cancers as well as several 
other human malignancies [18] suggesting that SIRT3 is 
a genomically expressed, mitochondrial localized tumor 
suppressor.  In addition, it has also been shown that the 
Sirt3 knockout mice are permissive for other age-related 
illnesses including fatty liver [13], insulin resistance 
[19], and cardiac hypertrophy [20,21].  These results 
identified Sirt3 as a more generalized mitochondrially 
fidelity protein and the mice lacking Sirt3 may be useful 
in vivo models to investigate human illnesses.  One 
intriguing finding from all of these manuscripts is that 
cells lacking Sirt3 exhibited altered mitochondrial 
metabolism as exhibited by increased mitochondrial 
ROS and superoxide levels during stress.  These results 
suggest that the aberrant regulation of the mitochondrial 
acetylome, which by definition occurs in murine cells 
lacking Sirt3, results in a phenotype permissive for 
mouse conditions that mimic human illness as well as 
suggest an underlying mechanism involving increased 
ROS and superoxide levels.   
 
MnSOD as a Sirt3 deacetylation target that directs 
enzymatic detoxification activity 
 
Manganese superoxide dismutase (MnSOD) is one of 
the primary mitochondrial antioxidant in a network of 
detoxification enzymes that neutralizes the highly 
reactive superoxide ions (O2•¯) to less reactive 
hydrogen peroxide (H2O2) followed by its immediate 
conversion to H2O by catalase and other peroxidases in 
the mitochondrial matrix [22].  Superoxide is the by-
product of electron transport chains I and III while they 
work inefficiently, and arises as a primary damaging 
reagent for mtDNA and other mitochondrial 
macromolecules [19,23]. ROS, in order of sequential 
reduction from O2, include superoxide (O2•¯), hydrogen 
peroxide (H2O2), hydroxyl radical (.OH), and organic 
peroxides, that are normally produced during respiration 
[24].  While low amounts of ROS are natural side 
products of various electron transfer reactions and 
easily tolerated by the cell, abnormally high levels of 
ROS from any number of possible sources induces 
oxidative stress and can damage cells by peroxidizing 
lipids, and disrupting proteins and nucleic acids [25,26]. 
Since MnSOD enzymatically scavenges superoxide, 
which is increased in cells lacking Sirt3 [27], it seemed 
logical to suggest that cells lacking Sirt3 might have 
altered regulation of MnSOD activity. 
 
The balance between the mitochondrial antioxidant 
detoxification system and ROS should be finely 
maintained while low levels mitochondrial ROS in are 
required by cells to modulate normal redox signaling 
networks. In addition, excessive amounts of ROS is 
believed to shortened life span [28] and induced age-
associated pathological conditions, such as 
carcinogenesis, cardiovascular, and other diseases 
[29,30].  While MnSOD
-/- mice are neonatal lethal the 
MnSOD
+/- mice display higher oxidative damage and 
incidence  of  tumor  formation  [31,32].  Mutations          
in  SOD2   were   associated   with   human   age-related   
   



































disorders, such as cardiomyopathy, neuronal diseases, 
and cancer [33-36].  These results clearly demonstrate 
the significant role for the aberrant regulation of 
MnSOD in age-related illnesses and suggest that 
upstream signaling proteins that regulate MnSOD may 
also play a role in these pathologies as well. 
 
There is an accumulating evidence that in specific solid 
tumors there is a very strong correlative statistically 
connection between aging as well as aberrant 
mitochondrial ROS regulation [37-39].  In this regard, 
the mice lacking Sirt3 appear to be an new in vivo 
model to investigate the connection between aging and 
carcinogenesis since these mice, at ages greater than 13 
months, developed well differentiated ER/PR receptor 
positive mammary tumors, which is the subtype of 
breast cancer that is most commonly observed in 
postmenopausal women [18].  Kim and his colleagues 
proposed that increased mitochondrial superoxide level 




































development in the older Sirt3 knockout mice. In 
addition to breast tissue, SirT3 deficient mouse 
hepatocytes and cardiomyocytes displayed significant 
mitochondrial superoxide levels [18,20]. Thus, it has 
been proposed that SIRT3 protects against ROS by 
enhancing the activity of antioxidant defense system, 
suggesting that this protein could be an imperative 
mitochondrial fidelity protein in the face of oxidative 
stress [18,20,40].  Based on these results our research 
group hypothesized that Sirt3 may bind to and regulate 
the enzymatic properties of MnSOD that detoxifies 
mitochondrial superoxide so as to prevent oxidative 
stress and cellular damage [41]. 
 
In this regard, we have recently shown in a manuscript 
published in Molecular Cell that MnSOD contains a 
reversibly acetylated lysine residue that is deacetylated 
by caloric restriction and 36 hours of fasting and 
MnSOD [41].  Purified MnSOD was also shown to be 
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wild-type, but not a deacetylation null, Sirt3 gene 
decreased MnSOD acetylation as well as increased 
MnSOD activity.  These results strongly suggested that 
Sirt3 deacetylation activity directly directs MnSOD 
acetylation status as well as its enzymatic detoxification 
activity [41]. 
 
It was also shown that MnSOD physically interacts with 
Sirt3 and lysine 122 is deacetylated by Sirt3, suggesting 
that acetylation of this lysine, at least in part, may 
regulate MnSOD function.  This idea was validated by a 
MnSOD mutant that demonstrated increased activity 
when lysine 122 was changed to arginine (to mimic the 
deacetylated state).  MnSOD
K122-R decreased superoxide 
levels in MEFs lacking MnSOD as well as prevented 
IR-induced transformation of MnSOD
-/- MEFs.   
Infection of MnSOD
K122-R into MEFs lacking Sirt3 also 
decreased cellular superoxide levels and reversed the 
tissue culture immortalization / transformation 
permissive phenotype observed in these primary cells.  
These results suggest that MnSOD amino acid K122, 
which is conserved in multiple complex and primitive 
species, including C. elegans, directs MnSOD 
enzymatic detoxification activity as well as plays a role, 
at least in part, the damage permissive phenotype 
observed in murine cells lacking Sirt3  [41].  Similar 
results for the role of Sirt3 regulation of MnSOD via 
acetylation has also be shown by the Chen laboratory 
[42] however, this group identified lysines 53 and 89 as 
acetylation targets that direct enzymatic function.  Thus, 
this implies that MnSOD may contain additional 
reversible acetyl lysines that determine enzymatic 
activity. 
 
In this manuscript we also showed livers from the Sirt3 
knockout mice exposed to 2 Gy of radiation on two 
consecutive days demonstrated an ionizing radiation-
induced damage permissive phenotype.  This was 
determined by radiation-induced liver periportal to 
midzonal hepatocellular swelling, dilation of the 
cytoplasm, poorly defined vacuoles, and increased 
apoptosis and ROS, specifically ONOO-, a reaction 
product of nitric oxide and superoxide [41]. This 
histology displays some characteristics similar to, at 
least in part, to that observed in microvesicular steatosis 
that is associated with mitochondrial dysfunction [43].  
Interestingly, the risk factors for steatosis include 
diabetes mellitus, protein malnutrition, and obesity [43], 
all of which have been associated with abnormalities of 
Sirtuin function [11].  These results suggest an 
oxidative stress permissive phenotype, including 
increase cellular superoxide levels, in liver cells lacking 
Sirt3.  These results as well as those observed by others 
for fatty liver [13], insulin resistance [19], and cardiac 
hypertrophy [20,21] clearly show that the mice lacking 
Sirt3 exhibit a cell damage permissive phenotype for 
age-related illnesses and strongly suggest a mechanisms 
involving aberrant accumulation of mitochondrial 
superoxide levels.  Finally, while the data does not 
definitively show that the aberrant acetylation a 
subsequent regulation of MnSOD is causative in these 
pathological processes, these results do make a strong 





The results discussed above suggest that loss of a single 
mitochondrial protein and the aberrant regulation of the 
mitochondrial acetylome signaling network that 
responds to metabolic demands and deacetylates 
downstream target proteins results in a phenotype 
permissive for human illnesses associated with aging.  
In this regard, MnSOD as well as several other recently 
identified mitochondrial proteins such as acetyl-CoA 
synthetase [15,44], glutamate dehydrogenase GDH) 
[44,45], long-chain acyl-CoA dehydrogenase (LCAD) 
[46], succinate Dehydrogenase [47], Ku70 [20], 
mitochondrial ribosome subunit MRPL10 [48], and 
isocitrate dehydrogenase [49].  These Sirt3 targets all 
appear to regulate critical mitochondrial enzymes that 
regulate energy metabolism and very strongly suggested 
that Sirt3 is a mitochondrial metabolism sensing protein 
maintains energy homeostasis responding to specific 
nutrient and environmental conditions.  As such, we 
believe the Sirt3 knockout mice represent a new 
paradigm that mechanistically links mitochondrial 
metabolism, the acetylome post-translation signaling 
network, and age-related disease including ER/PR 
breast cancer carcinogenesis, radiation-induced liver 
steatosis, fatty liver, insulin resistance, cardiac 
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